Bayer

Bio Roundup: Goodbye Belviq, LogicBio on Hold, Revolution's IPO & More

Bio Roundup: Goodbye Belviq, LogicBio on Hold, Revolution's IPO & More

10 days ago   |   Xconomy

Drugs typically go through three phases of clinical testing to support an application for FDA approval. It's easy to overlook Phase 4, which takes place after a drug reaches...
Read more ...

CEOs of Women's Health Companies Fight to Open Investment Floodgates

CEOs of Women's Health Companies Fight to Open Investment Floodgates

1 month ago   |   Xconomy

Talking about sex with potential investors? For EvoFem Biosciences CEO Saundra Pelletier, it's the first item on the docket. Her company recently submitted Amphora, a...
Read more ...

Bio Roundup: EQRx's Ambitions, Nektar No Vote, New Frazier Fund & More

Bio Roundup: EQRx's Ambitions, Nektar No Vote, New Frazier Fund & More

1 month ago   |   Xconomy

Perhaps the most talked-about news at the JP Morgan Healthcare Conference this week was a new startup that launched with $200 million and an ambitious claim its first drug...
Read more ...

Daré Bioscience Inks Deal With Bayer for Non-Hormonal Contraceptive

Daré Bioscience Inks Deal With Bayer for Non-Hormonal Contraceptive

1 month ago   |   Xconomy

Daré Bioscience launched in 2015 with the aim of assembling a portfolio of novel women's health products intended to pique interest from major pharmaceutical companies. Now the...
Read more ...

PACT Pharma bags $75M for neoantigen TCR work, manufacturing; Bayer grabs experimental contraceptive from Daré

1 month ago   |   San Diego Biotechnology

? With a new president and chief technical officer in place, next-gen T cell therapy player PACT Pharma has $75 million in fresh financing to expand the scope of its nascent...
Read more ...

 Bayer and Daré Bioscience Announce Exclusive Licensing Agreement for U.S. Commercial Rights to Ovaprene ®, an Investigational Hormone-Free, Monthly Contraceptive

1 month ago   |   San Diego Biotechnology

WHIPPANY, N.J. & SAN DIEGO--Bayer, a leader in women's health, and Daré Bioscience, Inc. , a clinical-stage biopharmaceutical company committed to the advancement of innovative...
Read more ...

Schrödinger adds another big Pharma partner; Grey Wolf raises $14 million to ‘illuminate' tumors

1 month ago   |   San Diego Biotechnology   |   2 articles

?Schrödinger has added yet another large pharma company to its list of partners. The New York-based biotech signed a €10 million deal to improve Bayer‘s drug discovery efforts...
Read more ...

After AstraZeneca, Sanofi deals, Schrödinger teams with Bayer to speed up drug work

1 month ago   |   Fierce Biotech   |   2 articles

New York-based Schrödinger and German pharma Bayer have penned a five-year drug trial tech deal aimed at boosting Bayer's drug discovery efforts.
Read more ...

Deciphera files for approval of cancer drug ahead of schedule

2 monthes ago   |   Fierce Biotech

Deciphera Pharmaceuticals has filed for FDA approval of ripretinib in patients with advanced gastrointestinal stromal tumors. The filing moves Deciphera closer to establishing...
Read more ...

Engineering Self-fertilizing Plants to Reduce Environmental Footprint

2 monthes ago   |   ISAAA

Scientists from Joyn Bio are attempting to engineer microbes that can make plants self-fertilizing, thus reducing the environmental impact of agriculture.Joyn Bio is a join...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Invetx Fetches $15M to Develop Biologic Drugs for Man's Best Friend

Invetx Fetches $15M to Develop Biologic Drugs for Man's Best Friend

Veterinarians have a saying that a cat is not a small dog, says Invetx CEO Juergen Horn. Obviously, a dog of any size isn't the same as a human. But Horn, a veterinarian, says... Read more ...

Lundbeck's Alder Bio Bet Pays Off With FDA Approval of Migraine Drug

Lundbeck's Alder Bio Bet Pays Off With FDA Approval of Migraine Drug

A migraine drug that Lundbeck added to its pipeline via its nearly $2 billion acquisition of Alder BioPharmaceuticals won FDA approval on Friday. The drug, eptinezumab , is... Read more ...

Arima Genomics Completes Series A Financing

SAN DIEGO--Arima Genomics, Inc., a company focused on research tools to accelerate the understanding of genome sequence and structure toward their role in human health and... Read more ...

Viking Therapeutics to Participate in Upcoming Investor Conferences

SAN DIEGO, Feb. 24, 2020 /PRNewswire/ - Viking Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and... Read more ...

Molecular characterization and overexpression analyses of secologanin...

Abstract Camptothecin is a high-value anti-cancerous compound produced in many taxonomically unrelated species. Its biosynthesis involves a complex network of pathways and a... Read more ...

Modulation of the Purine Pathway for Riboflavin Production in Flavinogenic...

Riboflavin is an indispensable nutrient for humans and animals, since it is the precursor of the essential coenzymes FMN and FAD, involved in variety of metabolic reactions... Read more ...

A Critical Review of Genome Editing and Synthetic Biology Applications in...

Being the green gold of the future, microalgae and cyanobacteria have recently attracted considerable interest worldwide, for they can be used to produce different kinds of... Read more ...

Biodegradation of penicillin G from industrial bacteria residue by...

An efficient biodegradation-strengthening approach was developed to improve penicillin G degradation from industrial bacterial residue in an expanded bed adsorption bioreactor... Read more ...

More clues for how the monkeyflower got its spots

The monkeyflower, or Mimulus, though possessing a relatively simple genome is able to produce a stunning array of pigmentation patterns. A team of researchers is one step... Read more ...

A deep dive into cellular aging

Scientists have discovered that mitochondria trigger senescence, the sleep-like state of aged cells, through communication with the cell's nucleus -a nd identified an... Read more ...